[April 17, 2014] |
|
Research and Markets: Global Mucositis Therapeutics Pipeline Review 2014 - Analysis of 5 Companies & 6 Drug Profiles
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/wd3j9s/mucositis)
has announced the addition of the "Mucositis
- Pipeline Review, H1 2014" report to their offering.
This report provides comprehensive information on the therapeutic
development for Mucositis, complete with comparative analysis at various
stages, therapeutics assessment by drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type, along with
latest updates, and featured news and press releases. It also reviews
key players involved in the therapeutic development for Mucositis and
special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D ppelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Mucositis
-
The report reviews key pipeline products under drug profile section
which includes, product description, MoA and R&D brief, licensing and
collaboration details & other developmental activities
-
The report reviews key players involved in the therapeutics
development for Mucositis and enlists all their major and minor
projects
-
The report summarizes all the dormant and discontinued pipeline
projects
-
A review of the Mucositis products under development by companies and
universities/research institutes based on information derived from
company and industry-specific sources
-
Pipeline products coverage based on various stages of development
ranging from pre-registration till discovery and undisclosed stages
-
A detailed assessment of monotherapy and combination therapy pipeline
projects
-
Coverage of the Mucositis pipeline on the basis of target, MoA, route
of administration and molecule type
-
Latest news and deals relating related to pipeline products
Mucositis - Companies Involved in Therapeutics Development
-
Piramal Enterprises Limited
-
Avaxia Biologics, Inc.
-
Tosk, Inc.
-
Rottapharm|Madaus
-
SciDose LLC
Drug Profiles
-
P-276
-
CR-3294
-
TK-112690
-
Small Molecule For Mucositis
-
Melatonin
-
AVX (News - Alert)-470
For more information visit http://www.researchandmarkets.com/research/wd3j9s/mucositis.
[ Back To TMCnet.com's Homepage ]
|